Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-Blind Parallel-group, Non-inferiority Phase II/III Study of the Safety and Effectiveness of BPL HRIG With Co Administration of Active Rabies Vaccine in Healthy Subjects

NCT03264157 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT03264157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-Blind Parallel-group, Non-inferiority Phase II/III Study of the Safety and Effectiveness of BPL HRIG With Co Administration of Active Rabies Vaccine in Healthy Subjects
Lead sponsor
Bio Products Laboratory
Phase
Phase 2/3
Overall status
Completed
Start date
December 8, 2017
Completion date
July 13, 2018
Enrollment
162 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy